Screener
Amphastar Pharmaceuticals AMPH Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
FAQ
- What is Amphastar Pharmaceuticals's restricted cash?
- Amphastar Pharmaceuticals (AMPH) reported restricted cash of $235K in Q2 2026.
- How has Amphastar Pharmaceuticals's restricted cash changed year-over-year?
- Amphastar Pharmaceuticals's restricted cash decreased by 0.0% year-over-year, from $235K to $235K.
- What is the long-term trend for Amphastar Pharmaceuticals's restricted cash?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's restricted cash has grown at a -33.9% compound annual growth rate (CAGR), from $1.87M to $235K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Amphastar Pharmaceuticals's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude